PSMA is a transmembrane glycoprotein expressed by the majority of PCa, with proven high detection rate at early BCR, which led PSMA PET to a grade A recommendation by the European Guidelines of PCa [16]. The gene discussed is BCR; the disease is posterior cortical atrophy.